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Abstract
Background: Molecular amplification techniques are suggested to be a useful adjunct in early detection of
pathogens in septic patients. The aim was to study the feasibility of a polymerase chain reaction (PCR) assay
compared to the standard microbiological culture (MC) technique in identification of pathogenic microorganisms
from blood and non-blood samples in septic patients.
Methods: Samples for pathogen identification were taken during febrile septic episodes (SE) in 54 patients with
sepsis and analyzed using both MC and PCR. Semi-automated multiplex PCR, provided by Philips Medical Systems,
was able to detect nine different pathogens. The accuracy of pathogen identification using PCR vs. MC as well as
the time-saving effect of PCR on the potential decision-making process for antimicrobial therapy was evaluated.
Results: In a total of 258 samples taken during 87 SE, both methods yielded more pathogens from the non-blood
than blood samples (87 % vs. 45 %; p = 0.002). PCR identified more pathogens than MC in the blood samples (98 vs.
21; p < 0.0001), but not in other body fluids. In 35 SE, the potential decision on appropriate antimicrobial therapy
based on PCR results could have been made 50 (median; interquartile range 35–87) hours earlier than decisions
based on standard MC.
Conclusions: In septic patients, multiplex PCR identified more pathogenic microorganisms isolated from the blood
samples than the standard MC technique. In the non-blood samples, PCR was comparable to that of MC.
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Background
Sepsis is a common infectious cause of morbidity, requir-
ing intensive care measures and immediate effective anti-
microbial therapy. Despite extensive therapeutic options,
mortality rates range from 10 to 20 % in patients with un-
complicated sepsis and up to 80 % in patients with septic
shock [1], ranking sepsis as the most common cause of
death in non-cardiac intensive care units [2].
The surgical removal of septic foci and an early adequate
administration of antimicrobial treatment dramatically
improve the clinical outcome of septic patients [3]. Inad-
equate initial antibiotic treatment significantly increases
the mortality rate [4]. Furthermore, delay in administration
of effective antimicrobial treatment increases mortality by
the hour [5, 6]. Prompt identification of the causative
pathogen and of its antimicrobial resistance pattern is of
crucial importance for effective treatment of sepsis [5].
The microbiological culture (MC) technique is the
conventional “gold standard” method for the identifica-
tion of bacterial and fungal infections in patients with
sepsis. However, sepsis diagnostics using microbiological
culture is possible only with viable pathogens. Their
growth time requires up to 48 h to yield the final result,
which may be negative in up to 30 % of cases [7, 8].
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Pre-treatment with antibiotic or antimycotic agents
has a negative impact on the growth of the causative
pathogen [9]. Nonetheless, despite a low sensitivity [10],
the positive results in blood culture guarantee the identi-
fication of the causative pathogen and its phenotype of
antimicrobial resistance, which is required for successful
treatment.
In recent decades, polymerase chain reaction (PCR)-
based molecular amplification techniques have been
suggested as a promising diagnostic tool for a faster iden-
tification of sepsis-causing pathogens [11–13], whereby
only blood samples are taken for sepsis diagnostics.
The aim of our investigation was to study the feasibil-
ity and accuracy of a PCR assay compared to the stand-
ard microbiological culture technique for detection of
pathogens in blood samples and samples of other body
fluids (bronchial secretions, wound fluid, abscess fluid,
smears, etc.) in patients with sepsis. In addition, we
wanted to evaluate the potential time-saving effect of
PCR on the decision-making process for the initiation of
antimicrobial treatment.
Methods
Patients and study design
This single-center investigation was performed at the sur-
gical intensive care unit of the tertiary hospital with a cap-
acity of 900 beds. The local ethics commission approved
the investigation; the consent of the patients for this ob-
servational study was not needed. All patients older than
18 years of age with a known or suspected focus of infec-
tion, and at least two clinical signs of systemic inflamma-
tory response syndrome (SIRS), were included in the
study. Diagnostic criteria for SIRS, sepsis, severe sepsis,
and septic shock were defined as proposed by the expert
committee of the American College of Chest Physicians
and the Society of Critical Care Medicine (ACCP/SCCM
1992) [14]. Patients with SIRS without a septic focus or
with a confirmed acute viral infection were not included
in the study.
This was a prospective observational laboratory and
clinical investigation. Blood samples and specimens of
other body fluids were taken from the suspected septic
foci in patients enrolled in the investigation according to
the above-described criteria. All samples were collected
using sterile technique for analysis of potential patho-
gens. The analysis was performed simultaneously using
standard MC techniques and a multiplex PCR proced-
ure. The anti-infective therapy of septic patients, which
was initially started as empiric treatment according to
current guidelines [15], was changed further only on the
basis of the MC diagnostics; the results of the PCR ana-
lysis were not disclosed to the attending physicians, so
the results of PCR diagnostics did not influence the ther-
apy of patients with sepsis, included in this investigation.
Sample collection
Blood sample collection was performed according to
microbiology procedure quality standards (MIQ) [16].
The blood samples were taken at septic episodes (SE),
when pyrexia, hypothermia, or chills were recorded. Sep-
tic episodes were defined according to ACCP/SCCM
sepsis definition [14]. If, despite anti-infective therapy,
the fever persisted, or if an increase of body temperature
or an increase of infectious parameters (procalcitonin,
C-reactive protein) occurred, the blood samples were
collected anew. At least 20 ml of blood was collected
per septic episode. Aerobic and anaerobic blood culture
bottles (BACTEC® PLUS™ Aerobic/F and Anaerobic/F,
Becton Dickinson Diagnostic Instrument Systems) were
inoculated with 9 ml of blood per bottle. The blood
(2 ml) was inoculated in an EDTA-Monovette® (Sarstedt)
for PCR analysis. Blood culture bottles were incubated
for a maximum of 9 days in a continuously monitored
incubator (BACTEC 9240; Becton Dickinson) at 37 °C.
Sample collection from other body fluids occurred as
ordered by the attending physician and as clinically indi-
cated according to the suspected septic focus. Samples
included tracheal and bronchial fluid, abscess and drain-
age fluid following surgical debridement, peritoneal fluid,
cerebral fluid, urine samples, and smears of wounds. To
allow simultaneous analysis with the two different tech-
niques, the samples were split in two under sterile con-
ditions. Samples for PCR analysis were stored at 7 °C
before processing. Samples for analysis using MC were
transported to the in-house microbiological laboratory
and retained until processing (depending on laboratory
working hours) according to in-house standards for
microbiology procedures (e.g., wound smears). Smears
were collected in cases where the body fluid collection
was not possible: two swab samples per infected area
were taken in order to allow analysis with both MC and
PCR techniques.
Multiplex PCR
To conduct the multiplex PCR, an experimental ar-
rangement of the commercial lab apparatus, designed
and provided by Philips Medical Systems (PMS) Böblin-
gen, Germany, was used. Sample processing and analysis
occurred in five steps. Step 1: cell lysis and DNA extrac-
tion were achieved using EZ1® cartridges (Qiagen, Venlo,
Holland); cells in the samples were destroyed by mech-
anical and chemical processes, and the released DNA
was bound to magnetic particles, washed several times,
and then eluted in water. Step 2: the extracted DNA was
incubated with specific primers in QIAGEN Multiplex
PCR Mastermix. Multiplex PCR Mastermix consisted of
HotStarTaq DNA Polymerase, QIAGEN Multiplex PCR
Puffer, 5× concentrated Q-solution, the dNTP Mix, and
RNase-free water. Both of these steps were performed
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on the fully automated EZ1 BioRobot® platform (QIAGEN).
Step 3: a thermocycler (PCR System 9700, ABI GeneAmp,
LifeTechnologies GmbH, Darmstadt, Germany) was used
for DNA amplification. Step 4: the pathogen’s (bacterial and
fungal) DNA was detected by means of electrophoresis
with “lab on a chip” technology (DNA 1000 LapChip® Kit,
Agilent Technologies, Frankfurt, Germany). Step 5: the iso-
lated pathogen DNA was identified by comparison with a
DNA ladder (BioAnalyzer 2100, Agilent Technologies).
Dilution of samples other than the blood occurred on a 1:5
or 1:10 basis using isotonic saline solution depending
on the viscosity of the sample fluid. If the PCR analysis
recorded high amounts of noise, analysis was repeated
in further dilution steps (1:50, 1:100). The samples for
PCR diagnostics arrived to the lab at latest in 60 min
following the samples collection and were immediately
processed.
Specific primers were developed by PMS for identifica-
tion of the causal microorganisms. The collected patient
samples were analyzed for the presence of nine frequent
sepsis pathogens: Staphylococcus aureus, Staphylococcus
epidermidis, Enterococcus faecium, Enterococcus faecalis,
Escherichia coli, Klebsiella pneumonie, Enterobacter clo-
acae, Pseudomonas aeruginosa, and Candida albicans.
Microbiological culture technique
The MC techniques were carried out at the microbio-
logical laboratory of the Dresden-Friedrichstadt hospital
according to the in-house standards. Positive blood cul-
ture samples and all non-blood samples were subject to
microscopic analysis using Gram staining. The attending
physicians were informed by a telephone call when micro-
scopic analyses revealed the presence of microorganisms.
All samples were cultivated under aerobic and anaerobic
conditions and standard incubation temperatures de-
pending on sample origin and suspected pathogen using
blood culture machines BACTEC 9240 (Becton Dickinson,
USA). The blood samples were incubated at 37 °C for max.
9 days. In case if the living microorganisms were present in
the blood, their growth caused the increase of CO2 in the
blood culture bottles. This increase was measured using the
increase of fluorescence by chemical sensor, which deliv-
ered both optical and acoustical signal. The precise identifi-
cation of the bacterial pathogens was performed using the
BD Phoenix™ Automated Microbiology System (Becton
Dickinson, USA). Analysis for growth of microorganisms
was performed after 24 h of incubation and further analysis
after 48 and 72 h. The first microbiological laboratory find-
ings were reported within 24 h. Standardized identification
and susceptibility tests were usually available after 48 h.
Within working hours, the samples reached the microbio-
logical laboratory in 30–60 min; if the samples were taken
in the night or over the weekend, the delay to arrival to the
lab could be maximally 16 h.
Samples evaluation and data analysis
The pathogen was considered as true positive (causal for
infection) if (i) this pathogen was found simultaneously
in two separate samples obtained from the same patient
using either of the detection techniques (MC or PCR),
(ii) the pathogen count, which was estimated semi-
quantitatively using the MC technique, was higher than
“moderate quantity” (Additional file 1), (iii) concentra-
tion of DNA of potential pathogen, which was amplified
in PCR, was higher than 0.2 ng/μl (in cases where the
identified microorganism in two separate samples could
present as a part of the physiological bacterial flora (in
case of non-blood samples), DNA concentrations greater
than 10 ng/μl were considered as a relevant pathogen),
and (iv) the clinical picture of infection corresponded to
the results of laboratory diagnostics. Conversion charts
are proposed in order to compare the results of the diag-
nostic techniques (Additional file 1).
The test results of both techniques were compared
and evaluated with reference to positive rates of samples
and the concordance of type and quantity of the de-
tected pathogens. To study the accuracy of the methods,
the test results were compared to the results of other ac-
companying investigation tests (blood or non-blood ma-
terial). The chi-square test was applied for dichotomous
data where appropriate. Furthermore, the time from the
sample collection to disclosure of test results was deter-
mined for both methods. The potential time-saving ef-
fect was calculated as the difference between the time
required for pathogen identification using MC technique




A total of 54 patients with clinical diagnosis of sepsis
were included in this study. The median age was 67 years
(range, 21–91 years). These patients developed 87 febrile
septic episodes, of which 4 were categorized as sepsis, 42
as severe sepsis, and 41 as septic shock (Table 1). In
total, 258 samples (180 blood samples and 78 samples of
other body fluids) were collected for analysis (Table 2,
Fig. 1), whereas 3 samples per patient per SE were col-
lected on average.
Blood vs. non-blood samples
Both MC and PCR techniques detected pathogens,
which caused sepsis, in 45 % of the blood samples vs.
87 % of the non-blood samples (p = 0.002; Fig. 1). One
hundred and eleven pathogens were identified by both
diagnostic techniques in 81 blood samples vs. 189 patho-
gens from 68 non-blood samples (p = 0.001; Fig. 1).
In the blood samples, PCR identified more pathogens
than MC (98 vs. 21; p < 0.0001), whereas the yield of
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both techniques from the non-blood samples was com-
parable (PCR 135 vs. MC 145, Fig. 2). In 2 (2 %) cases,
the pathogens could not be identified by PCR in the
blood samples due to the lack of primers vs. 35 (19 %)
cases in the non-blood samples (p = 0.0002; Fig. 2a).
Detailed description of pathogens identified by both
methods is given in Fig. 3. Forty-six of the 90 pathogens
identified by PCR were confirmed by detection in several
blood samples taken at the same time. Additional 24
pathogens were confirmed by means of PCR or MC in
other samples such as bronchial secrets, urine, abscess,
tip of central vein catheter, etc. In 20 pathogens, the
DNA concentration to be identified by PCR was higher
than 0.2 ng/μl. S. epidermidis, detected in 35 cases only
by PCR from the blood samples, was responsible for 14
septic episodes clinically associated with central venous
catheter infection.
Septic episodes
Both PCR and MC technique yielded negative results in
20 % of septic episodes and could detect the pathogens
in 46 % of 87 SE (Table 3). MC yielded positive results
(and PCR failed) in 3 % of SE, whereas PCR identified
organisms that were not detected by MC in 31 % of SE
(p = 0.001). Clinical details of SE where MC failed and
PCR could identify the septic pathogens are presented in
Additional file 2.
In four cases, the relevant pathogens, identified by
MC, were not recognized in the study samples by PCR
because the primers were not available. In another six
cases, relevant pathogens were not recognized by means
of PCR even though specific primers were used.
MC and PCR techniques identified the same patho-
gens in 35 SE. In 12 of them, the initial empiric anti-
infective therapy was confirmed by both methods and
continued. In 23 SE, the initial anti-infective therapy was
changed according to the results, which were confirmed
by both methods. During the diagnostics within these 35
SE, PCR was faster than MC in identification of patho-
genic microorganisms: the potential time-saving effect of
PCR was 50 (median; interquartile range 35–87) hours
(Additional file 3).
Discussion
In this prospective investigation, a multiplex PCR assay
was feasible for the identification of pathogenic microor-
ganisms along with the standard MC technique in pa-
tients with sepsis at the surgical intensive care unit. In
almost all septic episodes, both techniques confirmed
the clinical diagnosis of sepsis; none of clinical diagnoses
of sepsis was disapproved by these laboratory tech-
niques. Both PCR and MC techniques identified more
causative pathogens from the non-blood than from the
blood samples in septic patients, whereas PCR identified
more pathogens from the blood samples compared to
standard MC. This fact was restricted to the diagnostics
from the blood, but not from the non-blood samples; in
latter comparison, both diagnostic methods were equally
effective. Under clinical conditions, PCR required less
time than MC for identification of causative pathogens
from both the blood and non-blood samples taken dur-
ing SE in patients with sepsis. Regarding the reports
from other research groups comparing PCR and MC
techniques, this finding was well expected [11–13, 17, 18].
In 35 septic episodes, the PCR identified the causal patho-
gens 50 h earlier than the standard MC. In 27 SE, the
microbiology failed, and relevant pathogens were solely
detected by the use of PCR. These findings suggest the
clinical improvement in the identification of causal septic
pathogens and thus earlier initiation of causal anti-
infective therapy in the near future.
The higher diagnostic yield by both MC and PCR
techniques in the non-blood samples vs. the blood sam-
ples can be explained by the higher concentration of in-
tact viable pathogens in the non-blood samples, which
were not exposed to antibiotic agents [19].
Table 1 Septic episodes differentiated according to the site of
suspected focus and sepsis severity
Septic focus Severity of sepsis Total
Sepsis Severe sepsis Septic shock
Abdomen 1 8 11 20
Abscess 0 5 4 9
Central venous catheter 1 10 12 23
Lung 0 11 13 24
Genitourinary tract 1 2 0 3
Infected wound 1 4 0 5
Other 0 2 1 3
Total 4 42 41 87
Data are given as a number of septic episodes
Table 2 Number of the samples for pathogen identification
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The low sensitivity of MC of the blood samples in our
study confirmed the results of previous investigations,
where the causative pathogens of bacteremia in septic
patients could be identified in 6–23 % (increased to
69 % in septic shock) of cases using the standard MC
procedure [20, 21].
However, the positive rate of PCR technique with 98/
180 vs. MC with 21/180 was relatively higher (almost 5:1)
compared with those reported in previous studies using
multiplex PCR system. So Yanagihara et al. demonstrated
that SeptiFast PCR kit identified 24 pathogens vs. 11 by
MC technique out of 400 blood samples of septic patients
[11]. This discrepancy in the rate of pathogen detection,
which was even lower (2:1) in other investigations [12, 19],
can be explained by selection of patients: in contrast to
previous studies from internal medicine departments,
where approximately 70 % of patients revealed SIRS and
uncomplicated sepsis [11, 12, 19], almost 90 % of patients
from our investigation were in severe sepsis and septic
shock. Thus, it is possible that the blood samples of our
Fig. 1 Flow chart of the study with the number of pathogens, detected by both microbiological culture technique and multiplex PCR in patients
with sepsis at the intensive care unit (ICU). Both diagnostic techniques yielded more positive results and detected more septic pathogens in non-blood
samples as compared to blood samples. *p= 0.002; **p= 0.001; chi-square test
Fig. 2 Identification of septic pathogens from blood (a) and non-blood samples (b) using a microbiological culture (MC) technique and multiplex
PCR (PCR). Values are absolute numbers (percentage) of identified pathogens. *p = 0.0002; chi-square test
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Fig. 3 Number of various pathogens identified in a blood samples and b non-blood samples using microbiological blood culture technique
and PCR
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patients from surgical intensive care unit, who were
already pre-treated with antieffective drugs, contained high
concentration of non-viable pathogens, which was de-
tected by PCR but not by MC technique.
The detection of mainly staphylococci in 27 SE only
by PCR, where MC failed, might represent a false posi-
tive result. However, in our investigation, the detection
of S. aureus and S. epidermidis in 20 SE was correlated
with the clinical presentation of septic patients, where
19 out of 27 SE were diagnosed FUO and 1 with
catheter-associated infections. This finding is in agree-
ment with previous reports, where staphylococci were
found to be the cause of FUO in more than 50 % of
cases [22, 23].
Our finding that the results of PCR and MC diagnostics
of septic pathogens from the non-blood samples are com-
parable is in contrast with the results of Mencacci et al.,
who demonstrated that the commercial PCR-based system
SeptiFast yielded more positive results than MC (49 % vs.
19 %; p = 0.001) in the detection of microbial pathogens
from cardiac valve tissues and synovial and other purulent
body fluids [24]. This divergence in results can be ex-
plained by (i) different sample sources—in our study, the
non-blood samples were taken mainly from the bronchial
secretions and wound and abdominal lavage fluids—and
(ii) the broader spectrum of SeptiFast PCR, which is able
to identify 25 microbial agents [13, 22].
The known limitations of the MC technique, such as
poor sensitivity, time dependence, and false-negative re-
sults under antibiotic therapy [7–10, 17–21] require the
development of rapid reliable methods of pathogen iden-
tification such as PCR-based diagnostics. However, PCR
also reveals certain limitations. The detection of patho-
gen DNA is dependent on the availability of specific
primers [25]; in this study, we analyzed the samples for
the presence of only nine common sepsis pathogens.
Thus, two pathogens were not recognized in the blood
samples and 35 pathogens in the non-blood samples by
PCR due to lack of primers. Moreover, contamination is
a further problem of PCR-based diagnostic methods,
since they detect the pathogens only if specific DNA
segments are present, even from non-viable or already
phagocytized pathogens [26, 27]. On the other hand, the
PCR technique may yield false-negative results as well.
In our study, 11 pathogens were not identified in the
blood samples and 19 pathogens in the non-blood sam-
ples by means of PCR even though suitable primers were
used. Deficient primers, genetic mutations of the patho-
gens, cross-reactions with other DNA segments, or un-
stable connections of the primer to the DNA might be
the cause [13, 17].
The limitations of the present feasibility investigation,
performed in single institution, include the small num-
ber of the microorganisms, which could be identified by
PCR technique, as well as the small number of patients
with sepsis, included in this study. Moreover, due to ob-
servational design of the study, we can only postulate
the clinical significance of the results. We did not verify
whether the earlier identification of pathogens (and thus
earlier and more precise anti-infective therapy) might in-
fluence the outcome of the septic patients of this study.
However, regarding the available evidence about the
benefit of rapid diagnostics in patients with sepsis [3–6],
we presume the improved clinical prognosis due to early
identification of causative pathogens in our investigation.
Furthermore, in this study, we did not perform a cost-
effectiveness analysis, including the costs of antibiotic
treatment and its side effects, as well as personnel costs
and costs for hospital care.
Further steps might be a technical improvement of the
methodology, as well as an expansion of the range of
primers. The development of fully automated PCR diag-
nostics might prevent contamination as well as misinter-
pretation of the results. And, of course, the impact of
diagnostic advantages, given by PCR-based molecular
amplification techniques, on clinical outcome of anti-
infective therapy in patients with sepsis should be dem-
onstrated in a randomized clinical trial.
In summary, several investigations have demonstrated a
prognostic improvement in sepsis by timely adequate anti-
biotic treatment. The use of this time advantage, which is
promised by PCR-based techniques, might be an es-
sential step to improve the results of antibiotic ther-
apy in septic patients. Regarding the advantages and
limitations of both microbiological culture and PCR
procedures, these techniques should be performed in
parallel in order to achieve the optimal results in the
diagnostics of sepsis.
Conclusions
The multiplex PCR assay identified more pathogenic mi-
croorganisms than the standard microbiological culture
technique, when these pathogens were isolated from the
blood, but not from the non-blood samples in septic pa-
tients. PCR required less time than MC in the identifica-
tion of causal pathogens from both the non-blood and
blood samples. These findings might influence the im-
pact of PCR-based methods in the identification of
causal septic pathogens in clinical routine.
Table 3 Accuracy of pathogen detection during septic episodes
using PCR and microbiological blood culture (MC)
Septic episodes (n = 87) MC (−) MC (+) Total
PCR (−) 17 (20) 3 (3) 20 (23)
PCR (+) 27 (31) 40 (46) 67 (77)
Total 44 (51) 43 (49) 87
Data given as number (percent) of cases
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